Sclerosis Clinical Trials

• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Safety of RG2077 in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
  Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
  
• Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
  ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
  Multiple Sclerosis
  
• A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
  Multiple Sclerosis
  
• Auditory Function in Patients With and Without Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
  Multiple Sclerosis
  
• Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
  Multiple Sclerosis
  
• Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
  Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
  
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients with Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00006393 - Recruiting
  Systemic Sclerosis
  
• EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
  Multiple Sclerosis
  
• EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
  Multiple Sclerosis
  
• Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
  Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
  
• Improving Memory in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00062972 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00001248 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging to Detect Brain Damage in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00099307 - Recruiting
  Multiple Sclerosis
  
• Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
  ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
  Multiple Sclerosis
  
• Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
  Multiple Sclerosis
  
• GER-009-06-AVX Early Therapy in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis.
  ClinicalTrials.gov Identifier: NCT00235430 - Active, not recruiting
  Multiple Sclerosis
  
• Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00262314 - Active, not recruiting
  Multiple Sclerosis
  
• Zenapax to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00001934 - Active, not recruiting
  Multiple Sclerosis
  
• Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00289978 - Active, not recruiting
  Multiple Sclerosis
  
• Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00342134 - Active, not recruiting
  Multiple Sclerosis
  
• Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00381264 - Active, not recruiting
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00179478 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis; Transverse Myelitis; Acute Brainstem/Cerebellar Syndrome
  
• POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
  Multiple Sclerosis
  
• Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
  ClinicalTrials.gov Identifier: NCT00289159 - Active, not recruiting
  Multiple Sclerosis
  
• Atorvastatin Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00094172 - Recruiting
  Multiple Sclerosis
  
• A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00213824 - Recruiting
  Amyotropic Lateral Sclerosis
  
• Treatment of Multiple Sclerosis with Copaxone and Albuterol
  ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
  Autoimmune Diseases; Multiple Sclerosis
  
• Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00298662 - Active, not recruiting
  Multiple Sclerosis
  
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
  ClinicalTrials.gov Identifier: NCT00004645 - Active, not recruiting
  Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ...
  
• Safety Study of Oral Sodium Phenylbutyrate in Subjects with ALS (Amyotrophic Lateral Sclerosis)
  ClinicalTrials.gov Identifier: NCT00107770 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00004457 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment)
  ClinicalTrials.gov Identifier: NCT00185211 - Active, not recruiting
  Multiple Sclerosis
  
• Familial Amyotrophic Lateral Sclerosis. A Preliminary Study to Identify Subjects Who Might Be Willing to Participate in a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00136500 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00016458 - Active, not recruiting
  Systemic Sclerosis
  
• Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00339976 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• Early Treatment of Amyotrophic Lateral Sclerosis (ALS) with Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV)
  ClinicalTrials.gov Identifier: NCT00116558 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Study of Creatine Monohydrate in Patients with Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00069186 - Active, not recruiting
  Amyotrophic Lateral Sclerosis (ALS)
  
• Restoration of Walking in Multiple Sclerosis Using Treadmill Training.
  ClinicalTrials.gov Identifier: NCT00156676 - Recruiting
  Multiple Sclerosis
  
• Stress Management for Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00147446 - Recruiting
  Multiple Sclerosis
  
• A Study to Assess the Effects of MK-0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI.
  ClinicalTrials.gov Identifier: NCT00239655 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
  ClinicalTrials.gov Identifier: NCT00337779 - Active, not recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00071838 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00235989 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• A Phase 2 study in Multiple Sclerosis patients to determine the safety of different doses of RO0506997 compared to placebo and their effects on Multiple Sclerosis lesions.
  ClinicalTrials.gov Identifier: NCT00104143 - Not yet recruiting
  Multiple Sclerosis
  
• Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium
  ClinicalTrials.gov Identifier: NCT00176592 - Active, not recruiting
  Multiple Sclerosis
  
• Multiple Sclerosis Rehabilitation Study
  ClinicalTrials.gov Identifier: NCT00202254 - Active, not recruiting
  Multiple Sclerosis
  
• A Phase II Study Comparing Low- and High-Dose CAMPATH and High-Dose Rebif in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00050778 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
  ClinicalTrials.gov Identifier: NCT00379431 - Active, not recruiting
  Early and Severe Systemic Sclerosis
  
• Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00324454 - Active, not recruiting
  Motor Neuron Disease; Amyotrophic Lateral Sclerosis; Primary Lateral Sclerosis; Progressive Muscular Atrophy
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
  ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
  Multiple Sclerosis
  
• Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
  ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
  Multiple Sclerosis
  
• The Effects of TYSABRI Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00536120 - Recruiting
  Multiple Sclerosis
  
• Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study
  ClinicalTrials.gov Identifier: NCT00273364 - Recruiting
  Multiple Sclerosis
  
• High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
  ClinicalTrials.gov Identifier: NCT00288626 - Recruiting
  Multiple Sclerosis
  
• Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00475865 - Recruiting
  Multiple Sclerosis
  
• A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00512902 - Recruiting
  Alveolitis; Systemic Sclerosis
  
• A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00217295 - Recruiting
  Multiple Sclerosis
  
• TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00228228 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00321568 - Recruiting
  Multiple Sclerosis
  
• Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00334516 - Recruiting
  Cerebral Cortex Dysfunction
  
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00355134 - Recruiting
  Multiple Sclerosis
  
• Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00393588 - Recruiting
  Multiple Sclerosis
  
• Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00453752 - Recruiting
  Systemic Sclerosis
  
• Pilot Study of Teriflunomide as Adjunctive Therapy to Interferon-β in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00489489 - Recruiting
  Multiple Sclerosis
  
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00529581 - Recruiting
  Cognition Disorders; Multiple Sclerosis
  
• Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study One
  ClinicalTrials.gov Identifier: NCT00530348 - Recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two
  ClinicalTrials.gov Identifier: NCT00548405 - Recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00559702 - Recruiting
  Secondary Progressive Multiple Sclerosis
  
• Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
  ClinicalTrials.gov Identifier: NCT00232193 - Recruiting
  Relapsing-Remitting Multiple Sclerosis,; Mono-Symptomatic Multiple Sclerosis
  
• Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early MS Treatment With Betaseron
  ClinicalTrials.gov Identifier: NCT00461396 - Recruiting
  Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
  
• Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00300716 - Recruiting
  Multiple Sclerosis; Cognition Disorders
  
• Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00324506 - Recruiting
  Multiple Sclerosis
  
• Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
  ClinicalTrials.gov Identifier: NCT00331747 - Recruiting
  Multiple Sclerosis
  
• Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
  ClinicalTrials.gov Identifier: NCT00490789 - Recruiting
  Tuberous Sclerosis; Lymphangioleiomyomatosis
  
• Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00537082 - Recruiting
  Multiple Sclerosis
  
• Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00548769 - Recruiting
  Multiple Sclerosis
  
• Optic Neuritis Treatment Trial (ONTT)
  ClinicalTrials.gov Identifier: NCT00000146 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00140218 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
  Multiple Sclerosis
  
• AVONEX® Combination Trial - "ACT"
  ClinicalTrials.gov Identifier: NCT00112034 - Active, not recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00382629 - Active, not recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00296205 - Recruiting
  Multiple Sclerosis
  
• Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00432900 - Recruiting
  Multiple Sclerosis
  
• Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00468182 - Recruiting
  Multiple Sclerosis
  
• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00488839 - Recruiting
  Multiple Sclerosis
  
• Donor Stem Cell Transplantation for the Treatment of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00497952 - Recruiting
  Multiple Sclerosis
  
• Psychological Treatments for Scleroderma
  ClinicalTrials.gov Identifier: NCT00007267 - Active, not recruiting
  Pain; Depression; Scleroderma; Systemic Sclerosis
  
• Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00202410 - Recruiting
  Multiple Sclerosis
  
• Treatment of Early Systemic Sclerosis by Bosentan
  ClinicalTrials.gov Identifier: NCT00226889 - Recruiting
  Systemic Sclerosis (Scleroderma)
  
• Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00230204 - Recruiting
  Multiple Sclerosis
  
• Multiple Sclerosis and Heavy Progressive Resistance Training
  ClinicalTrials.gov Identifier: NCT00381576 - Recruiting
  Multiple Sclerosis
  
• Correlation Between Cognitive Functions and MRI in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00423111 - Recruiting
  Multiple Sclerosis
  
• Mycophenolate Mofetil in Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00433186 - Recruiting
  Diffuse Cutaneous Systemic Sclerosis
  
• Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00467584 - Recruiting
  Multiple Sclerosis